DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech ...
Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
The Department of Health and Human Services announced a set of new initiatives aimed at speeding up clinical trials by ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Jason is a general assignment ...
In 2013, the House Republican, who had become the party’s de facto “chief political strategist,” was at a Virginia resort with his colleagues, working to shift the GOP away from its stereotype as a ...
The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to ...
Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...
Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results